Skip to main content
Erschienen in: Neuroradiology 10/2005

01.10.2005 | Diagnostic Neuroradiology

Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age

Review of 50 consecutive patients aged 1 day–60 years

verfasst von: T. Krings, A. Ozanne, S. M. Chng, H. Alvarez, G. Rodesch, P. L. Lasjaunias

Erschienen in: Neuroradiology | Ausgabe 10/2005

Einloggen, um Zugang zu erhalten

Abstract

Hereditary haemorrhagic telangiectasia (HHT) is inherited as an autosomal dominant trait with varying penetrance and expressivity. Some of the most devastating consequences of this disease result from cerebral vascular malformations that manifest themselves in either arteriovenous fistulae (AVF), small nidus-type arteriovenous malformations (AVM) or micro-AVMs with a nidus less than 1 cm in size. The purpose of this study was to compare the phenotypes of CNS-manifestations of HHT with the age of the patient. The charts and angiographic films of 50 patients diagnosed with HHT according to the Curaçao criteria were retrospectively evaluated concerning age of onset of symptoms, or, if not applicable of first consultation. The files were reviewed for clinical presentation, family and personal history, while the patients’ angiograms were analysed with respect to the number of lesions (single and multiple), the location (superficial supratentorial, deep supratentorial, infratentorial, and spinal), and type of lesion (fistulous AVM, nidus-type AVM, and micro-AVM). A total of 75 central nervous system manifestations of HHT were found. Lesions included seven spinal cord AVFs that were all present in the paediatric age group (mean age: 2.2 years), 34 cerebral AV fistulae, all but two affected patients were less than 6 years (mean age 3.0). Sixteen nidus type AVMs (mean age: 23.1 years) and 18 micro-AVMs (mean age: 31.8 years) were found. HHT displays an age-related penetrance of clinical manifestations. Since members of the same family can present with completely different phenotypes of this disease there seems to be no relationship between the type of mutation and the phenotype of the disease. Since there seems to be a continuum of vascular abnormalities (from large fistulous areas to small AVMs and micro-AVMs) associated with HHT, the most likely determinating factor of the HHT phenotype is the timing of the revealing event in relation to the maturity of the vessel. Presumably, the trigger of the quiescent genetical abnormality transforms a “dormant” disease into a morphologically and therefore clinically detectable one by impairing a specific vessel segment at a specific (more or less vulnerable) period of time. The nature of this triggering event is, however, as of yet unclear.
Literatur
1.
Zurück zum Zitat Bideau A, Plauchu H, Brunet G, Robert J (1989) Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence. Population 44:3–22PubMed Bideau A, Plauchu H, Brunet G, Robert J (1989) Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence. Population 44:3–22PubMed
2.
Zurück zum Zitat Kjeldsen AD, Vase P, Green A (1999) Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 245:31–39CrossRefPubMed Kjeldsen AD, Vase P, Green A (1999) Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 245:31–39CrossRefPubMed
3.
Zurück zum Zitat Dakeishi M, Shioya T, Wada Y et al. (2002) Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 19:140–148CrossRefPubMed Dakeishi M, Shioya T, Wada Y et al. (2002) Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 19:140–148CrossRefPubMed
4.
Zurück zum Zitat Haitjema T, Disch F, Overtoom TT, Westermann CJ, Lammers JW (1995) Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 99:519–524CrossRefPubMed Haitjema T, Disch F, Overtoom TT, Westermann CJ, Lammers JW (1995) Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 99:519–524CrossRefPubMed
5.
Zurück zum Zitat McDonald JE, Miller FJ, Hallam SE, Nelson L, Marchuk DA, Ward KJ (2000) Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred. Am J Med Genet 93:320–327CrossRefPubMed McDonald JE, Miller FJ, Hallam SE, Nelson L, Marchuk DA, Ward KJ (2000) Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred. Am J Med Genet 93:320–327CrossRefPubMed
6.
Zurück zum Zitat Fulbright RK, Chaloupka JC, Putman CM et al. (1998) MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. Am J Neuroradiol 19:477–484PubMed Fulbright RK, Chaloupka JC, Putman CM et al. (1998) MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. Am J Neuroradiol 19:477–484PubMed
7.
Zurück zum Zitat Marchuk DA, Srinivasan S, Squire TL, Zawistowski JS (2003) Vascular morphogenesis: tales of two syndromes. Hum Mol Genet 12(1):R97–R112CrossRefPubMed Marchuk DA, Srinivasan S, Squire TL, Zawistowski JS (2003) Vascular morphogenesis: tales of two syndromes. Hum Mol Genet 12(1):R97–R112CrossRefPubMed
8.
Zurück zum Zitat Guttmacher AE, Marchuk DA, White RI Jr (1995) Hereditary hemorrhagic telangiectasia. N Engl J Med 333:918–924PubMed Guttmacher AE, Marchuk DA, White RI Jr (1995) Hereditary hemorrhagic telangiectasia. N Engl J Med 333:918–924PubMed
9.
Zurück zum Zitat Shovlin CL, Hughes JM, Tuddenham EG et al. (1994) A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 6:205–209CrossRefPubMed Shovlin CL, Hughes JM, Tuddenham EG et al. (1994) A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 6:205–209CrossRefPubMed
10.
Zurück zum Zitat McAllister KA, Baldwin MA, Thukkani AK et al. (1995) Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 4:1983–1985PubMed McAllister KA, Baldwin MA, Thukkani AK et al. (1995) Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum Mol Genet 4:1983–1985PubMed
11.
Zurück zum Zitat McAllister KA, Grogg KM, Johnson DW et al. (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345–351CrossRefPubMed McAllister KA, Grogg KM, Johnson DW et al. (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8:345–351CrossRefPubMed
12.
Zurück zum Zitat Pepper MS (1997) Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8:21–43CrossRefPubMed Pepper MS (1997) Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8:21–43CrossRefPubMed
13.
Zurück zum Zitat Attisano L, Carcamo J, Ventura F, Weis FM, Massague J, Wrana JL (1993) Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75:671–680CrossRefPubMed Attisano L, Carcamo J, Ventura F, Weis FM, Massague J, Wrana JL (1993) Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75:671–680CrossRefPubMed
14.
Zurück zum Zitat Shovlin CL, Hughes JM (1996) Hereditary hemorrhagic telangiectasia. N Engl J Med 334:330–331; author reply 331–332CrossRef Shovlin CL, Hughes JM (1996) Hereditary hemorrhagic telangiectasia. N Engl J Med 334:330–331; author reply 331–332CrossRef
15.
Zurück zum Zitat Shovlin CL, Guttmacher AE, Buscarini E et al. (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66–67CrossRefPubMed Shovlin CL, Guttmacher AE, Buscarini E et al. (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66–67CrossRefPubMed
16.
Zurück zum Zitat Begbie ME, Wallace GM, Shovlin CL (2003) Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J 79:18–24CrossRefPubMed Begbie ME, Wallace GM, Shovlin CL (2003) Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J 79:18–24CrossRefPubMed
17.
Zurück zum Zitat Shovlin CL, Letarte M (1999) Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 54:714–729PubMed Shovlin CL, Letarte M (1999) Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 54:714–729PubMed
18.
Zurück zum Zitat Garcia-Tsao G, Korzenik JR, Young L et al. (2000) Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 343:931–936CrossRefPubMed Garcia-Tsao G, Korzenik JR, Young L et al. (2000) Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 343:931–936CrossRefPubMed
19.
Zurück zum Zitat Matsubara S, Mandzia JL, ter Brugge K, Willinsky RA, Faughnan ME, Manzia JL (2000) Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. Am J Neuroradiol 21:1016–1020PubMed Matsubara S, Mandzia JL, ter Brugge K, Willinsky RA, Faughnan ME, Manzia JL (2000) Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. Am J Neuroradiol 21:1016–1020PubMed
20.
Zurück zum Zitat Mahadevan J, Ozanne A, Yoshida Y et al. (2004) Hereditary haemorrhagic telangiectasia. Cerebrospinal localization in adults and children. Review of 39 cases. Intervent Neuroradiol 10:27–35 Mahadevan J, Ozanne A, Yoshida Y et al. (2004) Hereditary haemorrhagic telangiectasia. Cerebrospinal localization in adults and children. Review of 39 cases. Intervent Neuroradiol 10:27–35
21.
Zurück zum Zitat Putman CM, Chaloupka JC, Fulbright RK, Awad IA, White RI Jr, Fayad PB (1996) Exceptional multiplicity of cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). Am J Neuroradiol 17:1733–1742PubMed Putman CM, Chaloupka JC, Fulbright RK, Awad IA, White RI Jr, Fayad PB (1996) Exceptional multiplicity of cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). Am J Neuroradiol 17:1733–1742PubMed
22.
Zurück zum Zitat Yasargil MG (1987) Pathological considerations. In: Yasargil MG (ed) Microneurosurgery, vol 3a. Thieme, Stuttgart, pp 63–64 Yasargil MG (1987) Pathological considerations. In: Yasargil MG (ed) Microneurosurgery, vol 3a. Thieme, Stuttgart, pp 63–64
23.
Zurück zum Zitat Yoshida Y, Weon YC, Sachet M et al. (2004) Posterior cranial fossa single-hole arteriovenous fistulae in children: 14 consecutive cases. Neuroradiology 46:474–481 Yoshida Y, Weon YC, Sachet M et al. (2004) Posterior cranial fossa single-hole arteriovenous fistulae in children: 14 consecutive cases. Neuroradiology 46:474–481
24.
Zurück zum Zitat Garcia-Monaco R, Taylor W, Rodesch G et al. (1995) Pial arteriovenous fistula in children as presenting manifestation of Rendu-Osler-Weber disease. Neuroradiology 37:60–64 Garcia-Monaco R, Taylor W, Rodesch G et al. (1995) Pial arteriovenous fistula in children as presenting manifestation of Rendu-Osler-Weber disease. Neuroradiology 37:60–64
25.
Zurück zum Zitat Willinsky R, Lasjaunias P, Comoy J, Pruvost P (1988) Cerebral micro arteriovenous malformations (mAVMs). Review of 13 cases. Acta Neurochir (Wien) 91:37–41CrossRef Willinsky R, Lasjaunias P, Comoy J, Pruvost P (1988) Cerebral micro arteriovenous malformations (mAVMs). Review of 13 cases. Acta Neurochir (Wien) 91:37–41CrossRef
26.
Zurück zum Zitat Mazighi M, Porter P, Alvarez H et al. (2000) Associated cererbal and spinal AVM in infant and adult. Report of two cases treated by endovascular approach. Intervent Neuroradiol 6:321–326 Mazighi M, Porter P, Alvarez H et al. (2000) Associated cererbal and spinal AVM in infant and adult. Report of two cases treated by endovascular approach. Intervent Neuroradiol 6:321–326
27.
Zurück zum Zitat Plauchu H, de Chadarevian JP, Bideau A, Robert JM (1989) Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32:291–297CrossRefPubMed Plauchu H, de Chadarevian JP, Bideau A, Robert JM (1989) Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32:291–297CrossRefPubMed
28.
Zurück zum Zitat Porteous ME, Burn J, Proctor SJ (1992) Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet 29:527–530PubMed Porteous ME, Burn J, Proctor SJ (1992) Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet 29:527–530PubMed
29.
Zurück zum Zitat Conway EM, Collen D, Carmeliet P (2001) Molecular mechanisms of blood vessel growth. Cardiovasc Res 49:507–521CrossRefPubMed Conway EM, Collen D, Carmeliet P (2001) Molecular mechanisms of blood vessel growth. Cardiovasc Res 49:507–521CrossRefPubMed
30.
Zurück zum Zitat Satomi J, Mount RJ, Toporsian M et al. (2003) Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia. Stroke 34:783–789CrossRefPubMed Satomi J, Mount RJ, Toporsian M et al. (2003) Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia. Stroke 34:783–789CrossRefPubMed
31.
Zurück zum Zitat Lasjaunias P (2000) Segmental identiy and vulnerability in cerebral arteries. Intervent Neuroradiol 6:113–124 Lasjaunias P (2000) Segmental identiy and vulnerability in cerebral arteries. Intervent Neuroradiol 6:113–124
32.
Zurück zum Zitat Bourdeau A, Cymerman U, Paquet ME et al. (2000) Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol 156:911–923PubMed Bourdeau A, Cymerman U, Paquet ME et al. (2000) Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol 156:911–923PubMed
33.
Zurück zum Zitat Sanchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabeu C (2002) Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem 277:43799–43808CrossRefPubMed Sanchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabeu C (2002) Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem 277:43799–43808CrossRefPubMed
34.
Zurück zum Zitat Sanchez-Elsner T, Botella LM, Velasco B, Corbi A, Attisano L, Bernabeu C (2001) Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 276:38527–38535 Sanchez-Elsner T, Botella LM, Velasco B, Corbi A, Attisano L, Bernabeu C (2001) Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem 276:38527–38535
Metadaten
Titel
Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age
Review of 50 consecutive patients aged 1 day–60 years
verfasst von
T. Krings
A. Ozanne
S. M. Chng
H. Alvarez
G. Rodesch
P. L. Lasjaunias
Publikationsdatum
01.10.2005
Erschienen in
Neuroradiology / Ausgabe 10/2005
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-005-1390-8

Weitere Artikel der Ausgabe 10/2005

Neuroradiology 10/2005 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Neurologie

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.